HEMARINA AND BREST UNIVERSITY HOSPITAL (CHRU DE BREST): OXYOP2 CLINICAL TRIAL TO EVALUATE EFFICACY OF UNIVERSAL OXYGEN CARRIER HEMO2LIFE® IN KIDNEY TRANSPLANTS PROCEEDS SUCCESSFULLY IN ALL FRENCH TRANSPLANT CENTERS
Morlaix, Brest (France), 26 November 2020 – Brest University Hospital and Hemarina, a biotech company based in Brittany, announced today
31 March 2021
